American Journal of Hematology

Top Research Topics at American Journal of Hematology?

The main points discussed in American Journal of Hematology deals with Internal medicine, Immunology, Gastroenterology, Pathology and Surgery. While American Journal of Hematology focused on Internal medicine, it was also able to explore topics like Endocrinology and Oncology. It dives deep in exploring the relationship between the study of Immunology and Disease.

The Pathology research presented places emphasis on topics like Bone marrow and Lymphoma. Surgery, which encompasses Chemotherapy and Transplantation, is the main subject of it. It explores topics in Leukemia which can be helpful for research in disciplines like Myeloid, Cancer research and Myeloid leukemia.

American Journal of Hematology investigates Anemia research which frequently intersects with Sickle cell anemia. The in-depth study on Sickle cell anemia also explores topics in the intersecting field of Hemoglobinopathy.

• Internal medicine (44.49%)
• Immunology (26.27%)
• Gastroenterology (15.90%)

What are the most cited papers published in the journal?

• Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis (996 citations)
• Hematological findings and complications of COVID-19. (713 citations)
• Autoimmune hemolytic anemia (510 citations)

Research areas of the most cited articles at American Journal of Hematology:

The published articles are organized to address concerns in the fields of Internal medicine, Immunology, Gastroenterology, Surgery and Pathology. Issues in Internal medicine were discussed in the journal publications, taking into consideration concepts from other disciplines like Endocrinology and Oncology. The works on Gastroenterology tackled in the most cited publications bring together disciplines like Survival analysis and Chemotherapy.

What topics the last edition of the journal is best known for?

• Internal medicine
• Disease
• Cancer

The previous edition focused in particular on these issues:

The journal mostly deals with topics like Internal medicine, Oncology, MEDLINE, Text mining and Gastroenterology. Multiple myeloma, Cohort, Myeloid leukemia, Retrospective cohort study and Transplantation are among the areas of Internal medicine tackled. The majority of Transplantation studies in American Journal of Hematology are focused on the subject of Hematopoietic stem cell transplantation.

Venetoclax, Regimen and Lenalidomide, Dexamethasone are some topics wherein Oncology research discussed in the journal have an impact. American Journal of Hematology connects research in Text mining with the related topic of Cancer research. The journal tackles research works in In patient as well as other disciplines like Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Coronavirus disease 2019 (COVID-19).

The most cited articles from the last journal are:

• Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination. (94 citations)
• Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: A propensity score-matched analysis. (30 citations)
• Immune thrombocytopenia in a 22-year-old post Covid-19 vaccine. (30 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in American Journal of Hematology (based on the number of publications) are:

• Ayalew Tefferi (173 papers) published 16 papers at the last edition, 3 more than at the previous edition,
• Barbara J. Bain (159 papers) published 16 papers at the last edition, 4 more than at the previous edition,
• Hagop M. Kantarjian (118 papers) published 14 papers at the last edition, 3 more than at the previous edition,
• Morie A. Gertz (95 papers) published 7 papers at the last edition, 4 less than at the previous edition,
• Elias Jabbour (87 papers) published 13 papers at the last edition, 5 more than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in American Journal of Hematology (based on the number of publications) are:

• Mayo Clinic (550 papers) published 46 papers at the last edition, 5 more than at the previous edition,
• Harvard University (335 papers) published 31 papers at the last edition, 8 more than at the previous edition,
• University of Texas MD Anderson Cancer Center (306 papers) published 30 papers at the last edition the same number as at the previous edition,
• Boston Children's Hospital (289 papers) published 15 papers at the last edition, 3 more than at the previous edition,
• French Institute of Health and Medical Research (187 papers) published 15 papers at the last edition, 6 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 2.71% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 44.01% were posted by at least one author from the top 10 institutions publishing in the journal. Another 9.47% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 17.83% of all publications and 28.69% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Educational Resources and Further Studies

For those interested in delving deeper into the medical discipline and becoming experts in areas discussed in the American Journal of Hematology, like Oncology, Endocrinology, and Immunology, further studies at highly-regarded institutions are recommended. For instance, the field of Hematology, which intersects significantly with Oncology, can be deeply explored through Nursing studies.

Nursing Studies provides a holistic exposure to the various medical disciplines, with a special emphasis on patient care. It is no secret that pursuing studies in a reputable institution contributes significantly to a comprehensive view of the medical field. Check out some of the best nursing schools in Minnesota for a sound start to your studies in medicine. These schools provide a great foundation for anyone planning to specialize in Hematology or any other medical specialization in the future. As an aspiring healthcare professional, it's crucial to seek the best education to prepare you for the exciting and rewarding challenges ahead.